Response of circulating heat shock protein 70 and anti-heat shock protein 70 antibodies to catheter ablation of atrial fibrillation

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Kornej, Jelena ^a   Reinhardt, Claudia ^a   Kosiuk, Jedrzej ^a   Arya, Arash ^a   Hindricks, Gerhard ^a   Adams, Volker ^a   Husser, Daniela ^a   Bollmann, Andreas ^a  

^a UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

Author keywords

AF recurrence; Atrial fibrillation; Autoantibodies; Catheter ablation; Heat shock proteins

Indexed keywords

AMIODARONE; AUTOANTIBODY; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CATHETER ABLATION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; QUANTITATIVE ANALYSIS; RECURRENCE RISK; REGRESSION ANALYSIS; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; AUTOANTIBODIES; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS;

EID: 84874095539     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-49     Document Type: Article

References (33)

1. Latchman DS. Heat shock proteins and cardiac protection. Cardiovasc Res 2001, 51:637-646. 10.1016/S0008-6363(01)00354-6, 11530097.
2. Xu Q, Hu Y, Kleindienst R, Wick G. Nitric oxide induces heat-shock protein 70 expression in vascular smooth muscle cells via activation of heat shock factor 1. J Clin Invest 1997, 100:1089-1097. 10.1172/JCI119619, 508283, 9276725.
3. Dybdahl B, Slordahl SA, Waage A, Kierulf P, Espevik T, Sundan A. Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart 2005, 91:299-304. 10.1136/hrt.2003.028092, 1768748, 15710705.
4. Genth-Zotz S, Bolger AP, Kalra PR, von Haehling S, Doehner W, Coats AJ, Volk HD. Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival. Int J Cardiol 2004, 96:397-401. 10.1016/j.ijcard.2003.08.008, 15301893.
5. Satoh M, Shimoda Y, Akatsu T, Ishikawa Y, Minami Y, Nakamura M. Elevated circulating levels of heat shock protein 70 are related to systemic inflammatory reaction through monocyte Toll signal in patients with heart failure after acute myocardial infarction. Eur J Heart Fail 2006, 8:810-815. 10.1016/j.ejheart.2006.03.004, 16714144.
6. Wright BH, Corton JM, El-Nahas AM, Wood RF, Pockley AG. Elevated levels of circulating heat shock protein 70 (Hsp70) in peripheral and renal vascular disease. Hear Vessel 2000, 15:18-22.
7. Brundel BJ, Henning RH, Ke L, van Gelder IC, Crijns HJ, Kampinga HH. Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation. J Mol Cell Cardiol 2006, 41:555-562. 10.1016/j.yjmcc.2006.06.068, 16876820.
8. Mandal K, Torsney E, Poloniecki J, Camm AJ, Xu Q, Jahangiri M. Association of high intracellular, but not serum, heat shock protein 70 with postoperative atrial fibrillation. Ann Thorac Surg 2005, 79:865-871. 10.1016/j.athoracsur.2004.08.018, 15734396.
9. St Rammos K, Koullias GJ, Hassan MO, Argyrakis NP, Voucharas CG, Scarupa SJ, Cowte TG. Low preoperative HSP70 atrial myocardial levels correlate significantly with high incidence of postoperative atrial fibrillation after cardiac surgery. Cardiovasc Surg 2002, 10:228-232. 10.1016/S0967-2109(01)00138-7, 12044430.
10. Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 2000, 6:435-442. 10.1038/74697, 10742151.
11. Afzal AR, Mandal K, Nyamweya S, Foteinos G, Poloniecki J, Camm AJ, Jahangiri M. Association of Met439Thr substitution in heat shock protein 70 gene with postoperative atrial fibrillation and serum HSP70 protein levels. Cardiology 2008, 110:45-52. 10.1159/000109406, 17934269.
12. Oc M, Ucar HI, Pinar A, Akbulut B, Oc B, Akyon Y, Kanbak M. Heat shock protein70: a new marker for subsequent atrial fibrillation development?. Artif Organs 2008, 32:846-850. 10.1111/j.1525-1594.2008.00640.x, 18959676.
13. Mandal K, Jahangiri M, Mukhin M, Poloniecki J, Camm AJ, Xu Q. Association of anti-heat shock protein 65 antibodies with development of postoperative atrial fibrillation. Circulation 2004, 110:2588-2590. 10.1161/01.CIR.0000136825.96029.A5, 15249499.
14. Oc M, Ucar HI, Pinar A, Akbulut B, Oc B, Akinci SB, Akyon Y. Heat shock protein 60 antibody. A new marker for subsequent atrial fibrillation development. Saudi Med J 2007, 28:844-847.
15. Matsuo S, Yamane T, Date T, Lellouche N, Tokutake K, Hioki M, Ito K. Dormant pulmonary vein conduction induced by adenosine in patients with atrial fibrillation who underwent catheter ablation. Am Heart J 2011, 161:188-196. 10.1016/j.ahj.2010.10.016, 21167353.
16. Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford EA, Cheetham ME. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 2009, 14:105-111. 10.1007/s12192-008-0068-7, 2673902, 18663603.
17. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010, 12:1360-1420.
18. Eitel C, Hindricks G, Sommer P, Gaspar T, Kircher S, Wetzel U, Dagres N. Circumferential pulmonary vein isolation and linear left atrial ablation as a single-catheter technique to achieve bidirectional conduction block: the pace-and-ablate approach. Hear Rhythm 2009, 7:157-164.
19. Kerr CR, Humphries KH, Talajic M, Klein GJ, Connolly SJ, Green M, Boone J. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J 2005, 149:489-496. 10.1016/j.ahj.2004.09.053, 15864238.
20. Gianfranchi L, Brignole M, Menozzi C, Lolli G, Bottoni N. Determinants of development of permanent atrial fibrillation and its treatment. Europace 1999, 1:35-39. 10.1053/eupc.1998.0008, 11220537.
21. de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ, van den Heijkant AC. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol 2010, 55:725-731. 10.1016/j.jacc.2009.11.040, 20170808.
22. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008, 51:802-809. 10.1016/j.jacc.2007.09.064, 18294563.
23. Wakisaka O, Takahashi N, Shinohara T, Ooie T, Nakagawa M, Yonemochi H, Hara M. Hyperthermia treatment prevents angiotensin II-mediated atrial fibrosis and fibrillation via induction of heat-shock protein 72. J Mol Cell Cardiol 2007, 43:616-626. 10.1016/j.yjmcc.2007.08.005, 17884089.
24. Ficker E, Dennis AT, Wang L, Brown AM. Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG. Circ Res 2003, 92:e87-100. 10.1161/01.RES.0000079028.31393.15, 12775586.
25. Costa VM, Silva R, Tavares LC, Vitorino R, Amado F, Carvalho F, Bastos Mde L. Adrenaline and reactive oxygen species elicit proteome and energetic metabolism modifications in freshly isolated rat cardiomyocytes. Toxicology 2009, 260:84-96. 10.1016/j.tox.2009.03.012, 19464573.
26. Xu Q, Schett G, Seitz CS, Hu Y, Gupta RS, Wick G. Surface staining and cytotoxic activity of heat-shock protein 60 antibody in stressed aortic endothelial cells. Circ Res 1994, 75:1078-1085. 10.1161/01.RES.75.6.1078, 7525102.
27. Baba A, Yoshikawa T, Fukuda Y, Sugiyama T, Shimada M, Akaishi M, Tsuchimoto K. Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur Heart J 2004, 25:1108-1115. 10.1016/j.ehj.2004.05.012, 15231368.
28. Stavrakis S, Yu X, Patterson E, Huang S, Hamlett SR, Chalmers L, Pappy R. Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism. J Am Coll Cardiol 2009, 54:1309-1316. 10.1016/j.jacc.2009.07.015, 2801559, 19778674.
29. Stein A, Wessling G, Deisenhofer I, Busch G, Steppich B, Estner H, Zrenner B. Systemic inflammatory changes after pulmonary vein radiofrequency ablation do not alter stem cell mobilization. Europace 2008, 10:444-449. 10.1093/europace/eun041, 18339614.
30. Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD, Wagner H. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem 2002, 277:15107-15112. 10.1074/jbc.M111204200, 11842086.
31. Liu T, Li G, Li L, Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 2007, 49:1642-1648. 10.1016/j.jacc.2006.12.042, 17433956.
32. Lin YJ, Tsao HM, Chang SL, Lo LW, Tuan TC, Hu YF, Udyavar AR. Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation. Am J Cardiol 2010, 105:495-501. 10.1016/j.amjcard.2009.10.019, 20152244.
33. Brundel BJ, Shiroshita-Takeshita A, Qi X, Yeh YH, Chartier D, van Gelder IC, Henning RH. Induction of heat shock response protects the heart against atrial fibrillation. Circ Res 2006, 99:1394-1402. 10.1161/01.RES.0000252323.83137.fe, 17110598.